Skip to content
10-K

Annual Report

Veradermics, Inc MANE

0001827635-26-000013

← back to feed
Filed
Mar 30, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 25, 2026 37.34M sh
Shares Diluted FY 2025 · Dec 31, 2025 744.99K sh
Shares Diluted FY 2025 · Dec 31, 2024 736.93K sh
Capex FY 2025 · Dec 31, 2025 $24K
Capex FY 2025 · Dec 31, 2024 $0
Operating Cash Flow FY 2025 · Dec 31, 2025 −$71.6M
Operating Cash Flow FY 2025 · Dec 31, 2024 −$23.69M
Cash And Equivalents FY 2025 · Dec 31, 2025 $21.77M
Cash And Equivalents FY 2025 · Dec 31, 2024 $53.08M
Stockholders Equity FY 2025 · Dec 31, 2025 −$121.01M
Stockholders Equity FY 2025 · Dec 31, 2024 −$48.48M
Stockholders Equity FY 2025 · Dec 31, 2023 −$22.24M
Current Liabilities FY 2025 · Dec 31, 2025 $9.15M
Current Liabilities FY 2025 · Dec 31, 2024 $4.72M
Total Liabilities FY 2025 · Dec 31, 2025 $9.16M
Total Liabilities FY 2025 · Dec 31, 2024 $4.72M
Current Assets FY 2025 · Dec 31, 2025 $152.49M
Current Assets FY 2025 · Dec 31, 2024 $55.54M
Total Assets FY 2025 · Dec 31, 2025 $152.62M
Total Assets FY 2025 · Dec 31, 2024 $55.54M
Eps Diluted FY 2025 · Dec 31, 2025 −$111.91
Eps Diluted FY 2025 · Dec 31, 2024 −$37.05
Eps Basic FY 2025 · Dec 31, 2025 −$111.91
Eps Basic FY 2025 · Dec 31, 2024 −$37.05
Sga Expense FY 2025 · Dec 31, 2025 $10.28M
Sga Expense FY 2025 · Dec 31, 2024 $3.5M
Rd Expense FY 2025 · Dec 31, 2025 $62.07M
Rd Expense FY 2025 · Dec 31, 2024 $23.28M
Net Income FY 2025 · Dec 31, 2025 −$70M
Net Income FY 2025 · Dec 31, 2024 −$26.49M
Operating Income FY 2025 · Dec 31, 2025 −$72.35M
Operating Income FY 2025 · Dec 31, 2024 −$26.78M